Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin | Synapse
March 3, 2026Open Access
Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin
Key Points
Elevated serum soluble ASGR1 concentration correlates with metabolic dysfunction associated with liver disease, indicating its potential as a biomarker.
In obese patients, ASGR1 levels associated with increased adiponectin and insulin resistance, showing how metabolic factors interplay.
Assessment of serum organokines among patients with steatosis provides insights into their role in liver inflammation and dysfunction.
Understanding serum ASGR1 levels may lead to better strategies for managing metabolic liver disease; further analysis is needed.
Abstract
The expression of organokines in serum and its relationship with inflammation, insulin resistance in obese patients, ChiCTR2200059056.